Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/Safety Comparison of AVT04 vs. Stelara in Healthy Adults
NCT04744363Phase 1Completed
- Sponsor
- Alvotech
- Start
- May 2021
- Primary completion
- Mar 2022
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
Phase 1, randomised, double-blind trial of AVT04 in psoriasis (3 arms), sponsored by Alvotech. Primary endpoints: Area under the plasma concentration-time curve from time zero to infinity at Day 92 and Maximum serum concentration at Day 92. Started May 2021; status: completed.
02
Drugs
AVT04
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT04744363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04744363.